Abstract
Purpose
To use novel indices to determine the prevalence of KC and its progression in patients aged 10–30 years with Down syndrome.
Study design
Cohort population-based study.
Methods
Two hundred twenty-six of 250 invited Down syndrome patients were enrolled. The diagnostic criteria were confirmed by two independent expert examiners using slit-lamp examinations and topographic indices measured by Pentacam HR (Oculus Optikgeräte): maximum keratometry centered on the steepest point (zonal Kmax-3 mm), Ambrósio's relational thickness (ART), inferior-superior asymmetry (IS-value), Belin/Ambrósio deviation value (BAD-D), the Tomographic and Biomechanical Index (TBI), and a posterior elevation map. In the KC cases, Corvis ST (Oculus Optikgeräte) was done. All the KC cases completed the second phase in 2017.
Results
KC was identified in 28 patients (12.39%; 95% confidence interval: 8.2–17.9%): 20 bilateral and eight unilateral cases. Of these, 24 were in the ≤ 20-years age group, and four, in the > 20-years age group. The frequency of KC was not significantly correlated with age (P = 0.804) or gender (P = 0.322). In the KC cases, the mean zonal Kmax-3 mm, ART-max, IS-value, BAD-D, CBI, and TBI were 50.40 ± 5.88 D, 321.63 ± 111.94 μm, 1.99 ± 2.51, 3.73 ± 3.12, 0.54 ± 0.61, and 0.86 ± 0.20, respectively, and the minimum corneal thickness was 492.17 ± 42.67 μm. Of the 28 patients, 39.6% showed progression, and all were in the ≤ 20-years age group.
Conclusion
The prevalence of KC in Down syndrome patients is significantly higher than that reported in non-Down syndrome individuals of the same age groups. The progression rate is approximately similar to that of the non-Down syndrome population. Screening programs should be applied to prohibit serious visual impairment in these populations.
Similar content being viewed by others
References
Hedayatfar A, Hashemi H, Aghaei H, Ashraf N, Asgari S. Subclinical inflammatory response: accelerated versus standard corneal cross-linking. Ocul Immunol Inflamm. 2019;27:513–6. https://doi.org/10.1080/09273948.2017.1420201.
Rabinowitz YS. Keratoconus. Surv Ophthalmol. 1998;42:297–319.
Torres Netto EA, Al-Otaibi WM, Hafezi NL, Kling S, Al-Farhan HM, Randleman JB, et al. Prevalence of keratoconus in paediatric patients in Riyadh, Saudi Arabia. Br J Ophthalmol. 2018;102:1436–41.
Hashemi H, Khabazkhoob M, Fotouhi A. Topographic keratoconus is not rare in an Iranian population: the Tehran Eye Study. Ophthalmic Epidemiol. 2013;20:385–91.
Wollensak G. Crosslinking treatment of progressive keratoconus: new hope. Curr Opin Ophthalmol. 2006;17:356–60.
Naderan M, Rajabi MT, Zarrinbakhsh P, Farjadnia M. Is keratoconus more severe in pediatric population? Int Ophthalmol. 2017;37:1169–73.
Léoni-Mesplié S, Mortemousque B, Mesplié N, Touboul D, Praud D, Malet F, et al. Epidemiological aspects of keratoconus in children [in French]. J Fr Ophtalmol. 2012;35:776–85.
Saee-Rad S, Raoofian R, Mahbod M, Miraftab M, Mojarrad M, Asgari S, et al. Analysis of superoxide dismutase 1, dual-specificity phosphatase 1, and transforming growth factor, beta 1 genes expression in keratoconic and non-keratoconic corneas. Mol Vis. 2013;19:2501–7.
Udar N, Atilano SR, Brown DJ, Holguin B, Small K, Nesburn AB, et al. SOD1: a candidate gene for keratoconus. Invest Ophthalmol Vis Sci. 2006;47:3345–51.
Aslan L, Aslankurt M, Yüksel E, Özdemir M, Aksakal E, Gümüşalan Y, et al. Corneal thickness measured by Scheimpflug imaging in children with Down syndrome. J AAPOS. 2013;17:149–52.
Gore DM, Watson MP, Tuft SJ. Permanent visual loss in eyes with keratoconus. Acta Ophthalmol. 2014;92:e244–e245245.
Shajari M, Jaffary I, Herrmann K, Grunwald C, Steinwender G, Mayer WJ, et al. Early tomographic changes in the eyes of patients with keratoconus. J Refract Surg. 2018;34:254–9.
Ambrósio R Jr, Caiado AL, Guerra FP, Louzada R, Sinha RA, Luz A, et al. Novel pachymetric parameters based on corneal tomography for diagnosing keratoconus. J Refract Surg. 2011;27:753–8.
Vinciguerra R, Elsheikh A, Roberts CJ, Ambrósio R Jr, Kang DS, Lopes BT, et al. Influence of pachymetry and intraocular pressure on dynamic corneal response parameters in healthy patients. J Refract Surg. 2016;32:550–61.
Roberts CJ, Mahmoud AM, Bons JP, Hossain A, Elsheikh A, Vinciguerra R, et al. Introduction of two novel stiffness parameters and interpretation of air puff-induced biomechanical deformation parameters with a dynamic Scheimpflug analyzer. J Refract Surg. 2017;33:266–73.
Rabinowitz YS, Rasheed K. KISA% index: a quantitative videokeratography algorithm embodying minimal keratometric criteria for diagnosing keratoconus. J Cataract Refract Surg. 1999;25:1327–35.
Burns DM, Johnston FM, Frazer DG, Patterson C, Jackson AJ. Keratoconus: an analysis of corneal asymmetry. Br J Ophthalmol. 2004;88:1252–5.
Villavicencio OF, Gilani F, Henriquez MA, Izquierdo L Jr, Ambrósio RR Jr, Belin MW. Independent population validation of the Belin/Ambrosio enhanced ectasia display: implications for keratoconus studies and screening. Int J Kerato Ectatic Corneal Dis. 2014;3:1–8.
Vinciguerra R, Ambrósio R Jr, Elsheikh A, Roberts CJ, Lopes B, Morenghi E, et al. Detection of keratoconus with a new biomechanical index. J Refract Surg. 2016;32:803–10.
Ambrósio R Jr, Lopes BT, Faria-Correia F, Salomão MQ, Bühren J, Roberts CJ, et al. Integration of Scheimpflug-based corneal tomography and biomechanical assessments for enhancing ectasia detection. J Refract Surg. 2017;33:434–43.
Kosekahya P, Caglayan M, Koc M, Kiziltoprak H, Tekin K, Atilgan CU. Longitudinal evaluation of the progression of keratoconus using a novel progression display. Eye Contact Lens. 2019;45:324–30. https://doi.org/10.1097/ICL.0000000000000582.
Haugen OH, Hovding G, Eide GE. Biometric measurements of the eyes in teenagers and young adults with Down syndrome. Acta Ophthalmol Scand. 2001;79:616–25.
Shapiro MB, France TD. The ocular features of Down's syndrome. Am J Ophthalmol. 1985;99:659–63.
Liza-Sharmini AT, Azlan ZN, Zilfalil BA. Ocular findings in Malaysian children with Down syndrome. Singap Med J. 2006;47:14–9.
Fimiani F, Iovine A, Carelli R, Pansini M, Sebastio G, Magli A. Incidence of ocular pathologies in Italian children with Down syndrome. Eur J Ophthalmol. 2007;17:817–22.
Shehadeh MM, Diakonis VF, Jalil SA, Younis R, Qadoumi J, Al-Labadi L. Prevalence of keratoconus among a Palestinian tertiary student population. Open Ophthalmol J. 2015;9:172–6.
Godefrooij DA, de Wit GA, Uiterwaal CS, Imhof SM, Wisse RP. Age-specific incidence and prevalence of keratoconus: a nationwide registration study. Am J Ophthalmol. 2017;175:169–72.
Pearson AR, Soneji B, Sarvananthan N, Sandford-Smith JH. Does ethnic origin influence the incidence or severity of keratoconus? Eye (Lond). 2000;14:625–8.
Baghdasaryan E, Huang X, Marion KM, Tepelus TC, Bagherinia H, Sadda SR, et al. Reproducibility of central corneal thickness measurements in normal eyes using the Zeiss Cirrus 5000 HD-OCT and Pentacam HR. Open Ophthalmol J. 2018;12:72–83.
Kosekahya P, Koc M, Caglayan M, Kiziltoprak H, Atilgan CU, Yilmazbas P. Repeatability and reliability of ectasia display and topometric indices with the Scheimpflug system in normal and keratoconic eyes. J Cataract Refract Surg. 2018;44:63–70.
de Luis EB, Escudero Argaluza J, Pijoan Zubizarreta JI, Santamaria Carro A, Etxebarria EJ. Evaluation of the reliability and repeatability of Scheimpflug system measurement in keratoconus. Cornea. 2018;37:177–81.
Alio JL, Vega-Estrada A, Sanz P, Osman AA, Kamal AM, Mamoon A, et al. Corneal morphologic characteristics in patients with Down Syndrome. JAMA Ophthalmol. 2018;136:971–8.
Choi JA, Kim MS. Progression of keratoconus by longitudinal assessment with corneal topography. Invest Ophthalmol Vis Sci. 2012;53:927–35.
Ferdi AC, Nguyen V, Gore DM, Allan BD, Rozema JJ, Watson SL. Keratoconus natural progression: a systematic review and meta-analysis of 11529 eyes. Ophthalmology. 2019;126:935–45. https://doi.org/10.1016/j.ophtha.2019.02.029.
Asgari S, Mehravaran S, Fotouhi A, Makateb A, Hashemi H. Total corneal refractive power and shape in Down syndrome. Eur J Ophthalmol. 2019. https://doi.org/10.1177/1120672119883594.
Acknowledgements
We thank Shiva Fayyaz who extracted the data and Dr Shiva Mehravaran who assisted us in the preparation of the manuscript.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest
H. Hashemi, None; M. Miraftab, None, K. Amanzadeh, None; M. A. Seyedian, None; R. Vinciguerra, Consultant fee (Oculus); R. Ambrósio Jr, Consultant fee (Oculus); C. Roberts, Consultant fee (Oculus, Ziemer); A. Makateb, None; P. Vinciguerra, Consultant fee (Oculus, Schwind); S. Asgari, None.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Corresponding Author: Soheila Asgari
About this article
Cite this article
Hashemi, H., Miraftab, M., Amanzadeh, K. et al. Keratoconus detection by novel indices in patients with Down syndrome: a cohort population-based study. Jpn J Ophthalmol 64, 285–291 (2020). https://doi.org/10.1007/s10384-020-00725-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10384-020-00725-4